Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery

European Heart Journal

Volumn 23, Issue 12, 2002, Pages 953-959

  Cotton, J M ^a   Mathur, A ^b   Hong, Y ^b   Brown, A S ^a   Martin, J F ^b   Erusalimsky, Jorge D ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Cardiovascular surgery; Cytokines; Growth factors; Human

Indexed keywords

INTERLEUKIN 6; PADGEM PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ERYTHROCYTE VOLUME; FEMALE; HEART VALVE REPLACEMENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; PLASMA; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; THORAX SURGERY; THROMBOCYTE COUNT; THROMBOCYTE MEMBRANE; THROMBOCYTE VOLUME; VASCULAR ENDOTHELIUM;

AGED; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERIOSCLEROSIS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; P-SELECTIN; POSTOPERATIVE PERIOD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0036623841     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3034     Document Type: Article

References (41)

1. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
2. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular specific growth factors and blood vessel formation, Nature 2000; 407: 242-8.
3. Ferrara N, Houck KA, Jakman LB, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
4. Connolly D, Huevelman DM, Nelson R et al. Tumour vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-8.
5. Clauss M, Gerlach M, Gerlach H et al. Vascular permeability factor: A tumour-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 1990; 172: 1535-45.
6. Zachary I, Mathur A, Yla-Herttuala S, Martin J. Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 2000; 20: 1512-20.
7. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-5.
8. Stavri GT, Hong Y, Zachary IC et al. Hypoxia and platelet derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 1995; 358: 311-15.
9. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649-52.
10. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1995; 92: 11-14.
11. Li J, Perrella MA, Tsai JC et al. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem 1995; 270: 308-12.
12. Cohen T, Nahari D, Weiss Cerem L, Neufield G, Levi B-Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996; 271: 736-41.
13. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in vivo. Nature 1992; 359: 845-8.
14. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc Res 1994; 28: 1176-9.
15. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thislethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction, N Engl J Med 2000; 342: 626-33.
16. Banai S, Jaklitsch MT, Shou M et al. Angiogenic-induced enhancement of collateral blood flow to ischaemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994; 89: 2183-9.
17. Inoue M, Itoh H, Ueda M et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-16.
18. Seko Y, Imai Y, Suzuki S et al. Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci 1997; 92: 453-4.
19. Hojo Y, Ikeda U, Zhu Y et al, Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 2000; 35: 968-73.
20. Kranz A, Rau C, Kochs M, Waltenberger J. Elevation of vascular endothelial growth factor-a serum levels following acute myocardial infarction. Evidence for its origin and functional significance. J Mol Cell Cardiol 2000; 32: 65-72.
21. Ikeda U, Ohkawa F, Seino Y et al. Serum Interleukin 6 Levels Become Elevated In Acute Myocardial Infarction. J Mol Cell Cardiol 1992; 24: 579-84.
22. Biasucci LM, Liuzzo G, Fantuzzi G et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999; 99: 2079-84.
23. Ikonomidis I, Andreotti F, Economou E, Stefanidis C,. Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100: 793-8.
24. Bruins P, te Velthuis H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery. Circulation 1997; 96: 3542-8.
25. Milner PC, Martin JF. Shortened bleeding time in acute myocardial infarction and its relation to platelet mass. Br Med J 1985; 290: 1767-70.
26. Martin JF, Daniel TD, Trowbridge EA. Acute and chronic changes in platelet volume and count after cardiopulmonary bypass induced thrombocytopaenia in man. Thromb Haemostas 1987; 57: 55-8.
27. Furman MI, Benoit SE, Barnard MR et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31: 352-8.
28. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-22.
29. Mohle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663-8.
30. Brown AS, Hong Y, de Belder A et al. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 802-7.
31. Erusalimsky JD, Martin JF. The regulation of megakaryocyte polyploidization and its implications for coronary artery occlusion. Eur J Clin Invest 1993; 23: 1-9.
32. Couffinhal T, Kearney M, Witzenbichler B et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic coronary arteries. Am J Pathol 1997; 150: 1673-85.
33. Berse B, Brown LF, Water LVD, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumours. Mol Cell Biol 1992; 3: 211-20.
34. Salgado R, Vermeulen PB, Benoy I et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer 1999; 80: 892-7.
35. Ladoux A, Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 1993; 195: 1001-5.
36. Tofukuji M, Metais C, Li J, Franklin A, Simons M, Selke FW. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia. Circulation 2000; 98: 242-8.
37. Burton PB, Owen VJ, Hafizi S et al. Vascular endothelial growth factor release following coronary artery bypass surgery: Extracorporeal circulation versus 'beating heart' surgery. Eur Heart J 2000; 21: 1649-51.
38. Schultz A, Lavie L, Hochberg I et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation. Circulation 1999; 100: 547-52.
39. Fleisch M,. Billinger M, Eberli FR, Garachemani AR, Meier B, Seiler C. Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation 2001; 103: E22.
40. Perez-Castellano N, Garcia EJ, Abeytua M et al. Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction. J Am Coll Cardiol 1998; 31: 512-18.
41. Luo Z, Diaco M, Murohara T, Ferrara N, Isner JM, Symes JF. Vascular endothelial growth factor attenuates myocardial ischaemia-reperfusion injury. Ann Thorac Surg 1997; 64: 993-8.